DXCM overview
DXCM

DXCMStock Forecast & Price Prediction

DexCom, Inc. · 20262027 outlook · as of July 27, 2026

Based on DexCom, Inc.'s historical trend and volatility, Invest's model projects a 12-month base-case price target of about $71.76 for DXCM — roughly +0.3% from the current $71.54 — within a range of $41.73 (bear) to $101.78 (bull). Invest's signal currently rates DXCM a Hold.

Current price

$71.54

Invest signal

Hold

12-mo expected

+0.3%

Volatility

49%

12-month price targets

Algorithmic scenarios from DXCM's historical trend and volatility.

Bull case
$101.78+42.3%

Momentum and conditions stay favorable.

Base case
$71.76+0.3%

The trend continues at a measured pace.

Bear case
$41.73-41.7%

Conditions weaken or the trend reverses.

Longer term, extending the base-case trend gives a rough 3-year target near $72.19.

How DXCM has performed

1 month

+2.6%

6 months

-3.2%

1 year

-17.2%

52-week range: $54.11$89.98.

How this forecast works: targets are generated by an algorithm from DXCM's historical price trend and volatility, dampened toward a long-run market average. They are illustrative and for educational purposes only — not financial advice. Markets are unpredictable and past performance does not guarantee future results.

Think the forecast is right? Test it — risk-free.

Practice trading DXCM with €1,000,000 in virtual cash at live prices.

Trade DXCM

DXCM forecast: FAQ

What is the DXCM stock forecast for 2026–2027?

Invest's model projects a 12-month base-case target of around $71.76 for DXCM (+0.3% from $71.54), with a bull case near $101.78 and a bear case near $41.73. These are algorithmic projections from historical price behavior, not guarantees.

Will DXCM stock go up?

No one can know for certain. Invest's signal weighs DXCM's trend, momentum and valuation and currently reads Hold, after falling 17% over the past year. The best way to test a thesis is to trade it risk-free in a simulator first.

Is DXCM a good long-term investment?

That depends on your goals and risk tolerance. For context, extending the base-case trend gives a rough 3-year target near $72.19 for DXCM. This is educational information, not financial advice — practice with virtual cash to learn how DXCM behaves before investing real money.

Can I practice trading DXCM for free?

Yes. Invest is a free stock market simulator — start with €1,000,000 in virtual cash and buy or sell DXCM at live market prices, with no real money and no risk. It runs in your browser and as a free iOS app.

More Healthcare forecasts